Health and Wellness : Ebola Watch: The Gambia, Nigeria, Mali, etc

Discussion in 'Black Health and Wellness' started by UBNaturally, Oct 20, 2014.

  1. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    There are discussions and ongoing efforts to conduct trial "Ebola River Virus" vaccines in three African countries that have had few to no cases of the symptoms related to the virus in other bordering countries.


    [​IMG]

    NIH to Launch Human Safety Study of Ebola Vaccine Candidate
    Thursday, Aug. 28, 2014

    The early-stage trial will begin initial human testing of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and will evaluate the experimental vaccine’s safety and ability to generate an immune system response in healthy adults. Testing will take place at the NIH Clinical Center in Bethesda, Maryland.


    Additionally, the U.S. Centers for Disease Control and Prevention has initiated discussions with Ministry of Health officials in Nigeria about the prospects for conducting a Phase 1 safety study of the vaccine among healthy adults in that country.


    As part of the VRC 207 trial, NIAID will also test a version of the NIAID/GSK vaccine that contains genetic material from only the Zaire Ebola species. Hence, this vaccine is referred to as a monovalent vaccine. This portion of the Phase 1 safety study, which will also involve 20 healthy adults, is expected to begin in October at the NIH Clinical Center and potentially another U.S. location. Dr. Ledgerwood will also lead that effort. The VRC 207 clinical trial is being conducted based on expedited review and approval by the U.S. Food and Drug Administration.

    In parallel, NIH has partnered with an international consortium that includes the British-based Wellcome Trust, as well as Britain’s Medical Research Council and Department for International Development to test the same NIAID/GSK monovalent vaccine candidate. The vaccine candidate will be tested among 60 healthy volunteers at the University of Oxford in England and among 40 healthy volunteers in Mali by the University of Maryland School of Medicine Center for Vaccine Development and its Center for Vaccine Development in Mali (a joint enterprise of the University of Maryland School of Medicine and the Ministry of Health of Mali). Additionally, the vaccine candidate is expected to be tested among 40 healthy volunteers in Gambia after approval from the relevant authorities.

    The Oxford trial is expected to launch in mid-September pending ethical and regulatory approval.

    “Today’s announcement shows how private and public partners can pull together to quickly respond to this critical public health emergency. Developing a new vaccine is complex with no guarantees of success, and we are still in the early days for our Ebola vaccine candidate. But we are encouraged by progress so far and will do the best we can, along with WHO and our partners, to speed up development and explore ways in which the vaccine could contribute to this or future Ebola outbreaks,” said Dr. Moncef Slaoui, chairman of Global R&D and Vaccines at GSK.

    Initial safety and immunogenicity data from the Phase 1 trials of the NIAID/GSK investigational Ebola vaccine are expected in late 2014.


    http://www.niaid.nih.gov/news/newsreleases/2014/Pages/EbolaVaxCandidate.aspx


    Testing of the vaccines will be in these locations:

    1. Maryland,
    2. University of Oxford in England,
    3. Mali,
    4. Gambia, and
    5. Nigeria


    Ebola vaccine trials to begin in Baltimore next month


    October 18, 2014

    An unusual request recently appeared in classifieds and on campus bulletin boards — Wanted: Baltimore-area volunteers to test a vaccine for the Ebola virus.

    The response was overwhelming, said Kirsten Lyke, an associate professor at the University of Maryland School of Medicine who is working on the study. The slots for the study were filled within days by people eager to help stop an epidemic that is paralyzing western Africa and panicking Americans.

    http://www.baltimoresun.com/health/bs-hs-ebola-vaccine-trial-20141018-story.html#page=1


    The is the WHO guideline for the vaccine trials:
    http://www.who.int/immunization/diseases/ebola/6-WHO_NewLink_v4.pdf?ua=1


    Just for those that are not aware of how these trails work on "healthy subjects", they would have to first administer the vaccine, then guess what they would have to do next to see if the vaccine is effective?

    Give the "healthy subject" the patented form of "Ebola" other wise called EboBun, named from the township of Bundibugyo, Uganda.


    GUP and PEP

    Immunize subjects, then challenge subjects

    upload_2014-10-20_19-31-55.png


    [0007] In late November 2007, HF cases were reported in the townships of Bundibugyo and Kikyo in Bundibugyo District, Western Uganda. The outbreak continued through January 2008, and resulted in approximately 149 cases and 37 deaths.

    Laboratory investigation of the initial 29 suspect-case blood specimens by classic methods (antigen capture, IgM and IgG ELISA) and a recently developed random-primed pyrosequencing approach identified this to be an Ebola HF outbreak associated with a new discovered ebolavirus species.

    These specimens were negative when initially tested with highly sensitive real-time RT-PCR assays specific for all known Zaire and Sudan ebolaviruses and Marburg viruses. This new species is referred to herein as "the Bundibugyo species", abbreviated "EboBun".

    [0008] Accordingly, compositions and methods directed to the new Ebola virus species are described herein and the most closely related Ebola Ivory Coast species, which compositions and methods are useful for diagnosis and prevention of human Ebola virus infection; including related vaccine development, and prevention of hemorrhagic fever in a human population.

    SUMMARY OF THE INVENTION

    [0009] The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun. EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda. The isolated virus is a member of the Filoviridae family, a family of negative sense RNA viruses. Accordingly, the invention relates to the isolated EboBun virus that morphologically and phylogenetically relates to known members filoviridae.

    [0010] In one aspect, the invention provides the isolated EboBun virus deposited with the Centers for Disease Control and Prevention ("CDC"; Atlanta, Georgia, United States of America) on November 26, 2007 and accorded an accession number 200706291, as stated in the paragraph entitled "DEPOSIT STATEMENT" supra.


    [0031] The invention further relates to the use of the sequence information of the isolated virus for diagnostic and therapeutic methods.

    [0032] In another aspect, the present invention provides methods for screening antiviral agents that inhibit the infectivity or replication of hEbola virus or variants thereof.

    Oxford, England is already in action.

    But let's keep our focus on Gambia, Nigeria and Mali.


    First, Mali:


    Problems in Ebola Border Areas - Mali's hospitals are overworked

    October 20, 2014

    There still hasn't yet been a case of Ebola in Mali. So Dr. Lanseni Doumbia can treat pregnant women, malaria sufferers and accident victims in his small hospital in Kourémalé. It's hoped things will remain that way, because facilities are unprepared for treating ebola victims.


    Video file:
    http://www.dw.de/embed/320/av-18008860


    Source:
    http://www.dw.de/problems-in-ebola-border-areas-malis-hospitals-are-overworked/av-18008860

    Will see how much they downplay Mali's health system over the next coming days, being that they have begun the "vaccine trials" earlier this month.

    If any news develops other than "Mali is still Ebola-free", it will be posted here.


    Will touch on Nigeria next,


    In view of all this, the pertinent question is why would the U.S. government claim to have invented Ebola and then claim an exclusive monopoly over its ownership?

    Another question that’s in need of an answer is whether the CDC hopes to collect a royalty on Ebola vaccines and also if it hopes to invent more variants and patent those too?

    Although the CDC’s patent on Ebola is partially focused on the methods for screening for Ebola and treating Ebola victims with drugs or vaccines, it beats the imagination as to why the American government would claim to have invented this infectious disease and then claim a monopoly over it.

    Source from Nigerian news:
    http://ynaija.com/united-states-government-patent-ebola-virus-invention-details/



    The Project Bioshield Act was an act passed by the United States Congress in 2004 calling for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack. This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines which had not been tested for safety or efficacy in humans, due to ethical concerns.

    Sources:
    Wikipedia.com
    http://georgewbush-whitehouse.archives.gov/infocus/bioshield/


    That's $500,000,000 a year for 10 years until 2014... this year
    Stockpiling and distribution of vaccines which had not been tested for safety in humans due to ethical concerns.


    The Project BioShield Act: Issues for the 113th Congress

    Frank Gottron
    Specialist in Science and Technology Policy
    June 18, 2014

    http://fas.org/sgp/crs/terror/R43607.pdf

    Use of Unapproved Countermeasures

    Congress modified some aspects of the HHS emergency use authority for medical countermeasures through PAHPRA. The HHS Secretary may now issue an EUA following the determination that a significant potential for a public health emergency exists. This authority now parallels other previously granted authorities to issue an EUA on the basis of potential military or domestic emergencies. Under PAHPRA, all EUAs expire when the HHS Secretary determines the underlying emergency circumstances no longer exist rather than automatically after one year as under previous law. It also permits the Secretary to modify active EUAs.

    The Secretary may now issue an EUA for counter measures against any agents that DHS has
    determined pose a material threat to national security. As discussed above, a material threat determination is required for all Project BioShield countermeasure acquisitions. Thus, the HHS Secretary can issue an EUA for all countermeasures acquired through Project BioShield, regardless of whether a separately declared emergency or potential emergency exists.

    This law also permits the mass dispensing of approved medical countermeasures during an
    emergency without an individual prescription. Previously such distribution would require an
    EUA. This law also permits federal, state, or local governments to pre-position or stockpile
    unapproved medical countermeasures in anticipation of emergencies.


    Posted this last bit of information to cover the basis of "declared or potential emergency" and "anticipation of emergencies".


    And I know this is a good deal of reading, but this is research and cross-referencing of information... not just simply posting links and articles.

    Hoping to spark questions or comments
     
  2. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    JAMMEH ASKS MEDICAL RESEARCH COUNCIL GAMBIA TO LEAVE FOLLOWING MRC'S REQUEST TO CONDUCT EBOLA VACCINE TRIAL

    October 6, 2014

    Yaya Jammeh has asked the Medical Research Council (MRC) Gambia to leave.

    The decision came about following the announcement by MRC UK, that they applied to The Gambia Government to conduct the Ebola Vaccine Trial in the UK and The Gambia. The Standard Newspaper of The Gambia reported an interview with Gambia's Health Minister, Omar Sey, that Gambia Government indeed received the MRC request and the matter was being considered.

    However, health officials and the Diplomatic Corps, coupled with MRC Management were astonished when State House informed Gambia Government's decision for MRC to leave The Gambia.

    The observers believed Jammeh's sole purpose was to continue his anti-United Kingdom sentiments against the good of our country. The MRC has been a force for good in The Gambia dating back years. They have trained and enhanced many Gambian health professionals; have been a partner to The Gambia Government's health policies over three decades, and continue to provide a valuable service to areas where government cannot cover.

    [​IMG]
    Unit Director Umberto D’Alessandro


    October 16, 2014

    There are recent reports that claim the decision for MRC to leave The Gambia has been cancelled
    The Gambia Government has revoked its recent decision to ask the MRC to leave The Gambia.


    Wonder if the trial vaccination study is a no go?
     
  3. crwn

    crwn Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 22, 2011
    Messages:
    914
    Likes Received:
    295
    Ratings:
    +458
  4. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    With the prediction/prophecy that Ghana would be dealing with the "Ebola" by October 31, 2014

    Ghana risks recording Ebola by October 31

    The research, conducted by the Northeastern University, USA, says countries with the largest probability of seeing the arrival of Ebola Viral Disease (EVD) cases before the end of October 2014 are Ghana, the United States, France, Senegal and Cote d’Ivoire.

    http://www.ghanaweb.com/GhanaHomePage/NewsArchive/artikel.php?ID=330315


    Ghana hasn't had any reported cases, but is there a push to make it seem otherwise?

    Man from Ghana sneezes in Prague and is escorted away with bag/jacket to hide identity




    A citizen of Ghana who returned to Facebook this month after nearly over a year away to proclaim:

    “People in the Western World need to know what’s happening here in West Africa. THEY ARE LYING!!!


    [​IMG]


    The Ghanaian, Nana Jovaun Kwame, goes on to write...


    “Ebola” as a virus does NOT Exist and is NOT “Spread”. The Red Cross has brought a disease to 4 specific countries for 4 specific reasons and it is only contracted by those who receive treatments and injections from the Red Cross. That is why Liberians and Nigerians have begun kicking the Red Cross out of their countries and reporting in the news the truth. Now bear with me:


    REASONS:
    Most people jump to “depopulation” which is no doubt always on the mind of the West when it comes to Africa. But I assure you Africa can NEVER be depopulated by killing 160 people a day when thousands are born per day. So the real reasons are much more tangible.


    Reason 1:
    This vaccine implemented sickness being “called” Ebola was introduced into West Africa for the end goal of getting troops on the ground in Nigeria, Liberia, and Sierra Leone. If you remember America was just trying to get into Nigeria for “Boko Haram”. ********. But that fell apart when Nigerians started telling the truth. There ARE NO GIRLS MISSING. Global support fell through the floor, and a new reason was needed to get troops into Nigeria and steal the new oil reserves they have discovered.

    [​IMG]



    Read more...
    http://www.realfarmacy.com/ebo-lie-man-living-ghana-confirms-ebola-hoax/

    Someone has made claim that he was a nurse, so not sure



    Not to stop there, this from Liberia...

    Ebola in Liberia under control – Liberia Embassy in Ghana
    12th October , 2014

    Liberian Ambassador to the United States, Jeremiah Sulunteh in an earlier interview with the media, said Liberia was close to collapsedue to "Ebola".

    The Charge D’Affairs of the Embassy of the republic of Liberia in Ghana, Musu Ruhle in an interview with Citi News refutted the claims.

    She indicated that the situation has greatly improved, “There are patients leaving the hospitals now who have been treated and are going home and we have empty beds. Before, two three months ago, there were no beds, but now there are empty beds,” she indicated.

    Source:
    http://www.citifmonline.com/2014/10/12/ebola-in-liberia-under-control-liberia-embassy-in-ghana/


    Then there is this...

    The Ebola Breakout Coincided with UN Vaccine Campaigns

    [​IMG]
    Yoichi Shimatsu, a Thailand-based science writer, organized public-health seminars by leading microbiologists and herbalists during the SARS outbreak in Hong Kong and the avian influenza crisis across Southeast Asia

    Thu, 10/09/2014

    The ebola pandemic began in late February in the former French colony of Guinea while UN agencies were conducting nationwide vaccine campaigns for three other diseases in rural districts. The simultaneous eruptions of this filovirus virus in widely separated zones strongly suggests that the virulent Zaire ebola strain (ZEBOV) was deliberately introduced to test an antidote in secret trials on unsuspecting humans.

    The cross-border escape of ebola into neighboring Sierra Leone and Liberia indicates something went terribly wrong during the illegal clinical trials by a major pharmaceutical company. Through the lens darkly, the release of ebola may well have been an act of biowarfare in the post-colonial struggle to control mineral-rich West Africa

    Earlier this year, rural residents eagerly stood in line to receive vaccinations from foreign-funded medical programs. Since the cover-up of the initial outbreak, however, panicked West Africans rural folk are terrified of any treatment from international aid programs for fear of a rumored genocide campaign. The mass hysteria is also fueled in a region traditionally targeted by Western pedophiles by the fact that filovirus survives longer in semen than in other body fluids, a point that resulted in murderous attacks on young men believed to be homosexuals. Ebola detonated fear and loathing, and perhaps that is exactly the intended objective of a destabilization strategy.

    This ongoing series of investigative journalism reports on the ebola crisis exposes how West Africans are largely justified in their distrust of the Western aid agencies that unleashed, whether by mistake or deliberate intent, the most virulent virus known to man.

    Full article below
    http://www.liberianobserver.com/commentaries/ebola-breakout-coincided-un-vaccine-campaigns




    Earlier this month, Liberian President Ellen Johnson Sirleaf went into action to protect the citizens of Liberia, buy cancelling elections and seeking to control speech, religion and property....



    Fearing Ebola, Liberia cancels democratic elections as President seeks to control, speech, religion and private property


    According to Voice of America (VOA), President Ellen Johnson Sirleaf has petitioned the national legislature to extend to her additional emergency powers in the name of preventing the further spread of the deadly virus.

    Currently, the country is already under a state of emergency, as well as a curfew, VOA reported, adding:

    In a letter to the Plenary of the House of Representatives and the Senate, Sirleaf asked for powers to amend seven different articles under the constitution, including freedom of movement, speech, religion, confiscation of private property, and elections.

    [​IMG]
    http://www.voanews.com/content/liberias-president-seeks-new-powers-to-fight-ebola/2476289.html

    'I will vote against it'

    Acarous Gray, a member of the House of Representatives from Congress for Democratic Change, an opposition party, has announced he will vote "no" on Sirleaf's request for new authoritarian powers. He said he will do so because he does not want to see a return to a military-style dictatorship for Liberia, outbreak or not.

    "In my view, this is dangerous, and it reminds us of the days when the dictators govern Liberia," he said, as reported by VOA. "While it is true that we have a state of emergency, the Liberian Constitution under Article 87 is very clear that during the state of emergency no provision of the constitution can be suspended. So, we cannot provide an absolute authority of such to the President that will be draconian. I will publicly advocate against it, and I will vote against it."


    Read more...
    http://www.naturalnews.com/047213_ebola_outbreak_democratic_elections_emergency_powers.html



    Legislature Overturns President’s Cancellation of Election

    Monrovia - A joint resolution of the Senate and House of Representatives of Liberia’s 53rd Legislature unanimously voted Friday to overturn a Presidential decision to cancel indefinitely, the scheduled midterm Senatorial elections this year.


    “Now, therefore, be it resolved, that the 53rd National Legislature through its special session during its extraordinary sitting mandates the National Elections Commission(NEC) to set a date in consultation with stakeholders for the conduct of the 2014 Mid Term Senatorial Elections not later than December 20, 2014. In overturning the presidential mandate, the joint legislature said their action was in keeping with Article 86(a) and (b) of the Liberia Constitution as they resolved that the Mid Term Elections be postponed.

    Source:
    http://www.frontpageafricaonline.co...verturns-president-s-cancellation-of-election

    By the way Liberia and Guinea are not party to the BWC Treaty that bans the use and testing of bio-chemical agents on citizens.

    upload_2014-10-22_12-4-2.png

    Source:
    http://www.opbw.org/new_process/msp2007/BWC_MSP_2007_4.pdf

    **Edited to reflect added parties from 2007 report crossed out


    Other sources:
    http://www.unog.ch/__80256ee6005859...fd5c?OpenDocument&ExpandSection=1,3#_Section1

    http://www.nti.org/treaties-and-reg...riological-biological-and-toxin-weapons-btwc/

    http://www.armscontrol.org/factsheets/bwcsig



    Ebola: WHO lists 15 priority countries

    WHO says it is focusing on 15 African countries to stop spread of disease, as EU reviews its screening policies.

    16 Oct 2014
    [​IMG]
    163 people were on board the Air France plane which arrived in Madrid from Paris [EPA]

    The WHO has said it is focusing its attention on 15 countries to prevent the spread of Ebola, as the EU announced a review of its entry policies and the disease was reported in the last untouched area of Sierra Leone.

    Dr Isabelle Nuttall, the WHO's global director, said on Thursday that cases were doubling every four weeks and that health officials were trying to prevent the disease spreading from Liberia, Sierra Leone and Guinea, the worst-hit nations, to neighbouring countries and those with a strong travel and trade relationship.

    Focus countries
    Ivory Coast, Guinea Bissau, Mali, Senegal, Benin, Burkina Faso, Cameroon, CAR, DR Congo, Gambia, Ghana, Mauritania, Nigeria, South Sudan and Togo.


    Source:
    http://www.aljazeera.com/news/europ...5-at-risk-countries-20141016125727852215.html
     
  5. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Mali has it's first case of Ebola
    October 23, 2014


    Tekmira and the University of Maryland have been targeting Mali since at least Aug. 28, 2014
     
  6. crwn

    crwn Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 22, 2011
    Messages:
    914
    Likes Received:
    295
    Ratings:
    +458
    #Ebola Czar Called Overpopulation Top Leadership Issue
     
  7. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Why the CDC, WHO, and all of Big Pharma does not want to cover the medical treatments in Africa, but will cover them within the US... new patents = new stocks = new investments = new currency.



    Ebola Update: Antiviral Med Passed NIH Aerosol Test in April, Another Reduces Lethality in Liberia

    Antivirals work. We know it from the lab. We know it from human clinical experience. Incorporating these resources ASAP with African health care is the big problem -- no question about it.

    Ebola is not invincible. And it can be fought without waiting for a vaccine.

    Where do we begin? Doing an Ebola Update we are struck right off that shockingly little press coverage in America is directed to Africa. What, we have a Lost Continent ??? That is where the action is, not Dallas. Not Lincoln. And what little appears in corporate MSM goes to images of the dead and dying.

    The processes underlying this West African epidemic receive no coverage.

    For example, the numbers for Ebola infected individuals are now doubling on an estimated 16 day cycle for city slums and 25 days for rural areas. Local sources indicate that Ebola has spread to Mali and Senegal from individuals acquiring Ebola hemorrhagic fever while visiting those countries, plus weaker indications/rumors connected to fresh graves in Benin and northern Nigeria.

    The big news -- confirmed yesterday -- is that African response to Ebola is still operating with no organized, supported access to generic antiviral medications. Nothing is being done to enhance Médecins Sans Frontières (MSF) services, the local doctors, or the hospitals.

    Big Biden Deal: the generic antivirals are not "Experimental Drugs" as described in corporate MSM and various pressers. The only part of it that's experimental is taking a drug that works with hepatitis, flu, HIV and using it with Ebola.

    The best known drug is Lamivudine (common commercial name, Epivir.) This was invented in 1988 at McGill University in Montreal. It has been used for severe viral infections ranging from Hepatitis-B to HIV. It is also used for flu outbreaks as in Japan. GlaxoSmithKline ceded production rights to its ViiV Healthcare venture. The drug costs $3 a pill in America (far less overseas) and grosses $500,000,000 a year. It has continuing successfully as a commercial product after the patents expired in 2010/2011.

    Lamivudine was approved for humans by the Food and Drug Administration in 1995. Beginning in August, 2014, Dr. Gorbee Logan, the physician at Tubmanburg, Liberia, treated 15 Ebola patients. Of these, 13 started treatment within 5 days of the first symptoms and all of the 13 survived. Unfortunately 2 other patients started treatment later in the cycle and they both died.

    This regime for treatment continues today. Similar results. The one and only limit is availability of Lamivudine in West Africa. AIDS clinics have it; others do not and that includes all of the small towns.

    You can think of Lamivudine as a generic antiviral. It blocks specific viral-induced DNA replication, but also inhibits RNA replication in certain circumstances. The mechanism suppresses viral replication, hopefully long enough for a human body to generate antibodies.

    Here's Tubmanburg, where these tests first succeeded:

    [​IMG]

    -- Contacts in Africa confirm that the Logan approach is being repeated with success though not quite the 100% success rate from Dr. Logan's first effort. Still, plainly, the earlier the generic antiviral is administered, the lower the mortality rate for Ebola patients.


    Source:
    http://www.dailykos.com/story/2014/...in-April-Another-Reduces-Lethality-in-Liberia



    These are a few of the initial reports from September

    Liberian Doctor Reduces Ebola Mortality Rate From 70% to 7% Using The AIDS Drug Epivir

    http://www.back2stonewall.com/2014/...ola-mortality-rate-70-7-aids-drug-epivir.html


    Doctor treats Ebola with HIV drug in Liberia -- seemingly successfully

    http://www.cnn.com/2014/09/27/health/ebola-hiv-drug/



    Now the question is:

    "Who cares for Africans in these areas, if the media and the puppets that follow the main stream media's talking point are all about American, UK and Swiss interests?"

    Some talk a good game while sounding just like the ones they are seemingly upset with.

    To have an "African" with a viable option version allowing our so called brothers and sisters to be used as walking laboratories while some enjoy Sunday Night Football and Walking Dead... I tell ya, I sometimes don't know who to build with anymore.


    One thing I know, Africans are stronger than most and will still be kicking long after the pseudo-pro-african whatever passes away in the US of A Inc.


    Anyone paying attention care to try to bring attention to what Dr. Gorbee Logan is doing and his need to get more supplies of the HIV anti-viral Lamivudine, instead of flooding the continent with experimental agents of biological genetic modification substances that are under "trial testing phases", do let me know as I will be investing some time into creating a campaign for the Dr.

    Dr.%20Logan%20presenting%20solidarity_web[1].jpg

    Tired of posting and posting and posting the mundane talking points of news clippings just because, which seems to be what most of social media has turned into.


    But just like with anything, many of us will lose because we are too busy being distracted with the things we enjoy arguing about.

    Link up to twitter.com and let's see if we can keep Africans on the front line, instead allowing outsiders to enter and claim victory as the typical story looks like it is trying to play out.

    #LamiGorbee



    Respect
     
  8. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    WHO sending experts to Mali after first Ebola diagnosis in the West African country

    October 24, 2014

    The World Health Organization is preparing to send a team of experts to Mali after the country announced that it had its first Ebola case, a WHO spokesperson said Friday.

    Mali's health minister said Thursday night that a 2-year-old girl who recently traveled from Guinea with her grandmother was admitted to a hospital in Kayes this week and tested positive for Ebola.


    Read more...
    http://www.washingtonpost.com/news/...-ebola-diagnosis-in-the-west-african-country/


    I wouldn't trust the words of this story too much, being that it never even mentions the experimental vaccine program that began in Mali on or around the 10th of October, before Mali had any cases of "Ebola".


    Reports: First confirmed Ebola patient in Mali dies

    October 24, 2014

    141024143723-01-obama-pham-hug-1024-horizontal-gallery[1].jpg

    Bamako, Mali (CNN) -- The first confirmed Ebola patient in Mali has died, according to state TV reports, citing government health officials.

    The victim, a 2-year-old girl, had traveled to the country with her grandmother from Guinea -- one of the three countries hardest hit during the recent Ebola outbreak.

    Earlier on Friday, the World Health Organization said that the girl had multiple opportunities to expose others to the virus.

    The girl first went to a clinic Tuesday after entering the country, WHO Assistant Director-General Marie-Paule Kieny said at a news conference in Geneva, Switzerland.


    Read more...
    http://www.cnn.com/2014/10/24/world/africa/mali-ebola/



    QUESTION:

    Who was the final decider upon the image to use for this article???
    Seriously

    obamaphamduncanfam.png


    Images usually say more than words anyway



    Ebola vaccine trials under way in Mali
    Country has no cases of disease, but researchers hope tests will succeed in protecting health workers on epidemic frontline

    Friday 10 October 2014

    Health workers in Mali have been given an experimental vaccine against Ebola designed to boost the immunity of those on the frontline of the battle against the disease, which has so far claimed more than 3,800 lives in west Africa.

    Three health workers in Mali have so far been vaccinated and 37 more will follow in the next few weeks. The vaccine is delivered by a cold virus, which does not cause any illness but delivers a single Ebola virus protein that is harmless by itself but can teach the immune system to recognise and respond to the whole virus in the future.

    The vaccine has been designed by the vaccine research centre of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. It is being manufactured by the British drug company GlaxoSmithKline and the funding is partly from the Wellcome Trust in the UK.


    Full article:
    http://www.theguardian.com/world/2014/oct/10/ebola-vaccine-mali-trialled-health-workers


    Experimental vaccines with Ebola virus protein are given to 40 people between October 10 and October 24, and then the first case of "Ebola" is reported... RIGHT!

    I wonder if any of them knew what they were part of this experiment?


    And for some that are not aware, Glaxo stocks were going down:


    GSK Troubles Extend Beyond China
    Fri, 07/25/2014 - 06:09 EDT - BidnessEtc

    GlaxoSmithKline plc (ADR) (GSK) once again finds itself in trouble, and this time it is not related to bribery allegations in China. The UK-based pharmaceutical saw its stock price dip 6% Tuesday after-hours when the company announced its second-quarter earnings for its fiscal ‘14 (2QFY14). Glaxo missed analysts’ revenue expectations of $9.8 billion (£5.75 billion)by 3.3% and earnings per share (EPS) estimate by $0.08 (£0.05).

    GSK has been caught up in bribery allegations in China where the company’s senior management has been accused of serious allegations. The probe alone has the potential of irreversibly damaging Glaxo’s image worldwide.

    • Furthermore, investors these days are focusing more on companies with a strong oncology pipeline and Glaxo sold off its cancer drugs to focus more on HIV and respiratory drugs.
    • GSK’s stock has lost more than 12% of its value in the past twelve months. The Dow Jones Pharmaceuticals Index has increased 19% in the same time frame.
    Source:
    http://www.bullfax.com/?q=node-gsk-troubles-extend-beyond-china#.dpuf
     
  9. chuck

    chuck Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Aug 9, 2003
    Messages:
    13,485
    Likes Received:
    2,103
    Gender:
    Male
    Ratings:
    +2,529
    Alleged conspiracies you overpost about:

    Real ones you don't even bring up!

    And would you claim we are all just hapless/helpless/victims etc. of white bigots/racists/reactionaries in high places too?

    Such defeatist and fatalistic attitudes continue to hog places/spaces/etc., whereas more balanced/candid/honest/etc. discussions/debates/etc. constantly get undermined, about what truly present challenges to our peoples continued existence, on the homefront...

    Only so much we can or should do for our distant african kinfolk: As is true of us too, some things we can and should do for ourselves!

    FYI
     
  10. UBNaturally

    UBNaturally Well-Known Member MEMBER

    Country:
    United States
    Joined:
    Jan 15, 2014
    Messages:
    6,497
    Likes Received:
    1,017
    Gender:
    Male
    Ratings:
    +1,736
    Liberians Won’t Be Used as Guinea Pigs’ For Ebola Trial Drugs not Approved


    [​IMG]

    Wed, 10/22/2014
    Health Products Regulatory Authority Warns
    By: Alaskai Moore Johnson, Observer Health Correspondent


    The Liberia Medicines & Health Products Regulatory Authority (LMHRA) has strongly warned pharmaceutical companies and others, who are trying to bring in “Ebola drugs/medicines,” for trial purposes, that Liberians won’t be used as Guinea pigs.

    LMHRA, which released a statement yesterday, is the Government of Liberia’s arm that has the statutory mandate to review and approve all clinical trials involving medicines and health products in the country.

    The Health Products Regulatory body said that “while we are seeking for all the help needed to eradicate this virus, we also want to be very careful as to what medicines are brought into the country for treatment at our various ETUs.”

    In the wake of the deadly Ebola Virus Disease (EVD) outbreak in the country that has claimed the lives of thousands of Liberians and other nationals, LMHRA said many “unapproved and unlicensed medicines have begun to line up as trial treatments for Ebola virus disease (EVD) in the country. In the midst of this situation, it has become necessary that the process of clinical trials be properly guided by policies and procedures for the safeguard of the population.”

    The health regulatory body said it has been forced to speak out having read in a local newspaper that a purported Ebola treatment drug, Eboflip, has arrived in the country for trial on patients at ETUs.

    “Eboflip, which is said to be indicated for the treatment of the Ebola Virus Disease, has no information on its pre-clinical safety data,” LMHRA said.

    Read more...
    http://www.liberianobserver.com/news/‘liberians-won’t-be-used-guinea-pigs’-ebola-trial-drugs-not-approved
     
Loading...